We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
+18.31%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.72B
AUM Growth
+$244M
Cap. Flow
+$33.9M
Cap. Flow %
1.25%
Top 10 Hldgs %
66.52%
Holding
104
New
19
Increased
17
Reduced
17
Closed
18

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$53.9M
2
WW
WW International
WW
+$15.8M
3
MA icon
Mastercard
MA
+$13.3M
4
DAL icon
Delta Air Lines
DAL
+$11.5M
5
FSL
FREESCALE SEMICONDUCTOR LTD
FSL
+$7.47M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$21.5M
2
AMZN icon
Amazon
AMZN
+$16.2M
3
C icon
Citigroup
C
+$15.1M
4
TEX icon
Terex
TEX
+$8.22M
5
ACOR
Acorda Therapeutics
ACOR
+$5.47M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33%
2 Healthcare 20.75%
3 Financials 0.8%
4 Technology 0.57%
5 Industrials 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTR icon
26
Nektar Therapeutics
NKTR
$2.39B
$19.9M 0.73%
110,000
+20,000
+22% +$3.83M
YUM icon
27
CALL
Yum! Brands
YUM
$41.9B
$18M 0.66%
347,750
– –
IONS icon
28
Ionis Pharmaceuticals
IONS
$8.93B
$17.7M 0.65%
455,000
– –
ITB icon
29
CALL
iShares US Home Construction ETF
ITB
$2.32B
$16.9M 0.62%
750,000
-750,000
-50% -$17.6M
IMGN
30
DELISTED
Immunogen Inc
IMGN
$15.9M 0.58%
1,500,000
– –
QCOM icon
31
CALL
Qualcomm
QCOM
$164B
$15M 0.55%
200,000
– –
V icon
32
CALL
Visa
V
$701B
$14.9M 0.55%
+280,000
New +$15M
GOOG icon
33
CALL
Alphabet (Google) Class C
GOOG
$4.11T
$14.4M 0.53%
501,373
-802,196
-62% -$23.2M
BMRN icon
34
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
$14.4M 0.53%
200,000
-200,000
-50% -$13.1M
HON icon
35
CALL
Honeywell
HON
$76.4B
$14M 0.51%
166,934
+55,645
+50% +$4.73M
CTSH icon
36
CALL
Cognizant
CTSH
$26.5B
$13.4M 0.49%
300,000
+100,000
+50% +$4.71M
C icon
37
CALL
Citigroup
C
$213B
$13M 0.48%
250,000
-250,000
-50% -$12.6M
MA icon
38
Mastercard
MA
$498B
$12.9M 0.48%
+175,000
New +$13.3M
APTV icon
39
Aptiv
APTV
$12.3B
$12.3M 0.45%
200,000
+50,000
+33% +$3.42M
AVNR
40
CALL
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$11.9M 0.44%
1,000,000
– –
AGIO icon
41
Agios Pharmaceuticals
AGIO
$2.08B
$11.7M 0.43%
190,000
+15,000
+9% +$647K
DAL icon
42
Delta Air Lines
DAL
$56.7B
$10.8M 0.4%
+300,000
New +$11.5M
ARRY
43
DELISTED
Array Biopharma Inc
ARRY
$10.7M 0.39%
3,000,000
– –
SLB icon
44
CALL
SLB Ltd
SLB
$72.7B
$10.2M 0.37%
+100,000
New +$10.9M
GM icon
45
General Motors
GM
$80.9B
$9.58M 0.35%
300,000
-50,000
-14% -$1.74M
UAL icon
46
CALL
United Airlines
UAL
$38.8B
$9.36M 0.34%
200,000
– –
BLUE
47
DELISTED
bluebird bio
BLUE
$8.97M 0.33%
19,300
– –
ACOR
48
DELISTED
Acorda Therapeutics
ACOR
$8.47M 0.31%
2,083
-1,459
-41% -$5.47M
COF icon
49
CALL
Capital One
COF
$128B
$8.16M 0.3%
100,000
– –
TFCFA
50
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$6.86M 0.25%
+200,000
New +$6.92M
1
2
3 4 5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q3 2014 Portfolio in Review

As of Q3 2014, Artal Group held 104 positions worth $2.72B, up 9.8% from $2.47B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Artal Group's Q3 2014 filing shows 19 new, 17 increased, 17 reduced and 18 closed positions. Its largest new stake was Alibaba: 600,000 shares worth $53.3M. The largest sale was AUXILIUM PHARAMCEUTICALS INC, an estimated $21.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Artal Group's largest Q3 2014 buy was Alibaba: 600,000 shares worth $53.3M.
  • Artal Group added most to WW International in Q3 2014, an estimated $15.8M increase.
  • Artal Group's biggest Q3 2014 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $21.5M.
  • Artal Group fully exited Amazon in Q3 2014, selling an estimated $16.2M.
  • Artal Group's ten largest holdings make up 67% of its $2.72B portfolio in Q3 2014.
  • Artal Group opened 19 new positions and closed 18 in Q3 2014.
  • Artal Group's portfolio value rose 9.8% quarter-over-quarter to $2.72B.

Based on Artal Group's 13F filing for Q3 2014, filed 13 Nov 2014.